Article: SARS coronavirus detection methods

File Download Links for fulltext
(May Require Subscription)
Supplementary
  • Basic View
  • Metadata View
  • XML View
TitleSARS coronavirus detection methods
AuthorsLau, SKP2
Che, XY1
Woo, PCY2
Wong, BHL2
Cheng, VCC2
Woo, GKS2
Hung, IFN3
Poon, RWS2
Chan, KH2
Peiris, JSM2
Yuen, KY2
Issue Date2005
PublisherUS Department of Health and Human Services, Centers for Disease Control and Prevention. The Journal's web site is located at http://www.cdc.gov/ncidod/EID/index.htm
CitationEmerging Infectious Diseases, 2005, v. 11 n. 7, p. 1108-1111 [How to Cite?]
AbstractUsing clinical samples from patients with severe acute respiratory syndrome, we showed that the sensitivities of a quantitative reverse transcription-polymerase chain reaction (80% for fecal samples and 25% for urine samples) were higher than those of the polyclonal (50% and 5%) and monoclonal (35% and 8%) antibody-based nucleocapsid antigen capture enzyme-linked immunosorbent assays.
ISSN1080-6040
2011 Impact Factor: 6.169
2011 SCImago Journal Rankings: 0.476
ISI Accession Number IDWOS:000230106600022
ReferencesReferences in Scopus
DC Field
Value
dc.contributor.authorLau, SKP
dc.contributor.authorChe, XY
dc.contributor.authorWoo, PCY
dc.contributor.authorWong, BHL
dc.contributor.authorCheng, VCC
dc.contributor.authorWoo, GKS
dc.contributor.authorHung, IFN
dc.contributor.authorPoon, RWS
dc.contributor.authorChan, KH
dc.contributor.authorPeiris, JSM
dc.contributor.authorYuen, KY
dc.date.accessioned2010-09-06T07:51:41Z
dc.date.available2010-09-06T07:51:41Z
dc.date.issued2005
dc.description.abstractUsing clinical samples from patients with severe acute respiratory syndrome, we showed that the sensitivities of a quantitative reverse transcription-polymerase chain reaction (80% for fecal samples and 25% for urine samples) were higher than those of the polyclonal (50% and 5%) and monoclonal (35% and 8%) antibody-based nucleocapsid antigen capture enzyme-linked immunosorbent assays.
dc.description.natureLink_to_subscribed_fulltext
dc.identifier.citationEmerging Infectious Diseases, 2005, v. 11 n. 7, p. 1108-1111 [How to Cite?]
dc.identifier.epage1111
dc.identifier.hkuros109605
dc.identifier.isiWOS:000230106600022
dc.identifier.issn1080-6040
2011 Impact Factor: 6.169
2011 SCImago Journal Rankings: 0.476
dc.identifier.issue7
dc.identifier.openurl
dc.identifier.pmid16022791
dc.identifier.scopuseid_2-s2.0-21144451304
dc.identifier.spage1108
dc.identifier.urihttp://hdl.handle.net/10722/79190
dc.identifier.volume11
dc.languageeng
dc.publisherUS Department of Health and Human Services, Centers for Disease Control and Prevention. The Journal's web site is located at http://www.cdc.gov/ncidod/EID/index.htm
dc.publisher.placeUnited States
dc.relation.ispartofEmerging Infectious Diseases
dc.relation.referencesReferences in Scopus
dc.subject.meshEnzyme-Linked Immunosorbent Assay - methods
dc.subject.meshFeces - virology
dc.subject.meshHumans
dc.subject.meshNucleocapsid Proteins - isolation & purification
dc.subject.meshReverse Transcriptase Polymerase Chain Reaction - methods
dc.subject.meshSARS Virus - isolation & purification
dc.subject.meshSensitivity and Specificity
dc.subject.meshSevere Acute Respiratory Syndrome - diagnosis - urine
dc.titleSARS coronavirus detection methods
dc.typeArticle
Author Affiliations
  1. Southern Medical University
  2. The University of Hong Kong
  3. Queen Mary Hospital Hong Kong